Lexapro and Ddd - a phase IV clinical study of FDA data

Summary:

Ddd is reported as a side effect among people who take Lexapro (escitalopram oxalate), especially for people who are female, 50-59 old, have been taking the drug for 5 - 10 years also take Zometa, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Ddd when taking Lexapro. It is created by eHealthMe based on reports of 82,231 people who have side effects when taking Lexapro from the FDA, and is updated regularly.

What is Lexapro?

Lexapro has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 91,444 Lexapro users. Check the latest studies of Lexapro.

What is Ddd?

Ddd is found to be associated with 1,411 drugs and 1,390 conditions by eHealthMe. Check the latest studies of Ddd.

On Oct, 20, 2025

82,231 people reported to have side effects when taking Lexapro.
Among them, 498 people (0.61%) have Ddd.

Among these 498 people:

How long have people been on Lexapro when they have Ddd? *

What is the gender of people who have Ddd when taking Lexapro? *

female: 73.9 %
male: 26.1 %

What is the age of people who have Ddd when taking Lexapro? *

What are other drugs people take besides Lexapro? *

What are other side effects people have besides Ddd? *

Pain: 333 people, 66.87%
Back Pain: 287 people, 57.63%
Osteonecrosis Of Jaw (death of bone of jaw): 263 people, 52.81%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 216 people, 43.37%
Anaemia (lack of blood): 205 people, 41.16%
Spinal Osteoarthritis (joint cartilage loss in spine): 203 people, 40.76%
Joint Pain: 196 people, 39.36%
Pain In Extremity: 183 people, 36.75%
Fatigue (feeling of tiredness): 172 people, 34.54%
Dyspnea (difficult or laboured breathing): 169 people, 33.94%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 69 people, 13.86%
Osteoporosis (bones weak and more likely to break): 66 people, 13.25%
High Blood Pressure: 61 people, 12.25%
Pain: 61 people, 12.25%
Metastases To Bone (cancer spreads to bone): 45 people, 9.04%
Diabetes: 42 people, 8.43%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 39 people, 7.83%
Sleep Disorder: 36 people, 7.23%
Breast Cancer: 35 people, 7.03%
Muscle Spasms (muscle contraction): 34 people, 6.83%

* Approximation only. Some reports may have incomplete information.

Do you take Lexapro and have Ddd?

- Check whether Ddd is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lexapro:

Lexapro (91,444 reports)

Ddd treatments and more:

Ddd (19,905 reports)

Browse all side effects of Lexapro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common drugs associated with Ddd:

Fosamax side effect: Ddd (3,047 reports)
Zometa side effect: Ddd (2,149 reports)
Prednisone side effect: Ddd (1,905 reports)
Aspirin side effect: Ddd (1,558 reports)
Humira side effect: Ddd (1,378 reports)
Aredia side effect: Ddd (1,331 reports)
Gabapentin side effect: Ddd (1,258 reports)
Methotrexate side effect: Ddd (1,183 reports)
Vioxx side effect: Ddd (1,076 reports)
Celebrex side effect: Ddd (1,050 reports)

Browse all the drugs that are associated with Ddd:

Ddd (1,411 drugs)

Common conditions associated with Ddd:

Browse all the conditions that are associated with Ddd:

Ddd (1,390 conditions)

Drugs similar to Lexapro and Ddd :

Related publications that referenced our studies

O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on escitalopram oxalate (the active ingredients of Lexapro) and Lexapro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.